This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
This article compares yields from SP 500 funds and multi-asset retirement portfolios, detailing factors that influence income streams.
25,151 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A year-long selloff in monday.com highlights how a single large exit can ripple through stock prices, risk, and inves...
Nuclear expansion plans are accelerating, and uranium ETFs are drawing fresh attention. A look at URA, URNM, URNJ, NL...
As the Fed began cutting rates, investors wondered if floating rate loans could still shield income portfolios. A clo...
Can the steady, branch-backed lender OneMain outpace the AI-powered growth of Upstart? This guide breaks down the str...
A specialized REIT with cannabis-related tenants moved higher in today’s session. This article breaks down the factor...
A crypto veteran nicknamed the 'godfather crypto' argues Bitcoin could reach $1 million in time, yet warns that a nea...
A sudden price collapse in a toll-tech stock creates a rare chance for patient investors. This guide explains how to ...
Ripple CEO Brad Garlinghouse signals a turning point as Wall Street embraces XRP-inspired infrastructure, marking a s...
Dallas Wings star Azzi Fudd joins Project B, signaling a bold shift in how athletes monetize careers through a planne...
As Bausch Health prepares its Q4 2025 results, investors want clarity on margins, debt, and the pipeline. This guide ...
FMC Corporation has faced headwinds that can derail even strong portfolios. Here are two words that should make inves...